0	0	1999-09-22	CD	O	O	B-Num
0	1	19	CD	O	O	B-Num
0	2	:	:	O	O	I-Num
0	3	16	CD	O	B-NP	I-Num
0	4	RESEARCHERS	NNS	O	I-NP	B-ProfTitle
0	5	DISCOVER	NNP	O	O	O
0	6	POSSIBLE	NNP	O	O	O
0	7	MUSCLE-RESTORATION	NNP	O	O	O
0	8	TECHNIQUE	NNP	O	O	O

1	0	BROOKLINE	NNP	O	B-NP	O
1	1	COMMA	COMMA	O	O	O
1	2	Mass.	NNP	O	O	O
1	3	_	NN	O	O	O
1	4	A	DT	O	B-NP	O
1	5	surprising	JJ	O	I-NP	O
1	6	finding	NN	O	I-NP	O
1	7	by	IN	O	B-PP	O
1	8	researchers	NNS	O	B-NP	B-ProfTitle
1	9	at	IN	O	B-PP	O
1	10	Children	NNP	O	B-NP	B-Org
1	11	's	POS	O	B-NP	O
1	12	Hospital	NNP	O	I-NP	O
1	13	suggests	VBZ	O	B-VP	O
1	14	that	DT	O	O	O
1	15	bone	NN	O	B-NP	O
1	16	marrow	NN	O	I-NP	O
1	17	transplants	NNS	O	I-NP	O
1	18	might	MD	O	B-VP	O
1	19	be	VB	O	I-VP	O
1	20	a	DT	O	B-NP	O
1	21	new	JJ	O	I-NP	O
1	22	strategy	NN	O	I-NP	O
1	23	for	IN	O	B-PP	O
1	24	restoring	VBG	O	B-VP	O
1	25	strength	NN	O	B-NP	O
1	26	to	TO	O	B-PP	O
1	27	patients	NNS	O	B-NP	O
1	28	with	IN	O	B-PP	O
1	29	muscular	JJ	O	B-NP	B-Medical
1	30	dystrophy	NN	O	I-NP	I-Medical
1	31	and	CC	O	O	O
1	32	other	JJ	O	B-NP	O
1	33	muscle-wasting	JJ	O	I-NP	O
1	34	diseases	NNS	O	I-NP	O
1	35	.	.	O	O	O

2	0	In	IN	O	B-PP	O
2	1	preliminary	JJ	O	B-NP	O
2	2	experiments	NNS	O	I-NP	O
2	3	COMMA	COMMA	O	O	O
2	4	the	DT	O	B-NP	O
2	5	scientists	NNS	O	I-NP	B-ProfTitle
2	6	infused	VBN	O	O	O
2	7	mice	NNS	O	B-NP	B-Animal
2	8	weakened	VBN	O	B-VP	O
2	9	by	IN	O	B-PP	O
2	10	muscular	JJ	O	B-NP	B-Medical
2	11	dystrophy	NN	O	I-NP	I-Medical
2	12	with	IN	O	B-PP	O
2	13	special	JJ	O	B-NP	O
2	14	bone	NN	O	I-NP	O
2	15	marrow	NN	O	I-NP	O
2	16	stem	VBP	O	B-VP	B-Jour
2	17	cells	NNS	O	B-NP	I-Jour
2	18	taken	VBN	O	B-VP	O
2	19	from	IN	O	B-PP	O
2	20	healthy	JJ	O	B-NP	O
2	21	donor	NN	O	I-NP	B-Medical
2	22	mice	NNS	O	I-NP	B-Animal
2	23	.	.	O	O	O

3	0	As	IN	O	O	O
3	1	expected	VBN	O	B-VP	O
3	2	COMMA	COMMA	O	O	O
3	3	the	DT	O	B-NP	O
3	4	stem	VBP	O	B-VP	B-Jour
3	5	cells	NNS	O	B-NP	I-Jour
3	6	generated	VBD	O	B-VP	O
3	7	new	JJ	O	B-NP	O
3	8	bone	NN	O	I-NP	O
3	9	marrow	NN	O	I-NP	O
3	10	and	CC	O	I-NP	O
3	11	blood	NN	O	I-NP	O
3	12	cells	NNS	O	I-NP	O
3	13	in	IN	O	B-PP	O
3	14	the	DT	O	B-NP	O
3	15	sick	JJ	O	I-NP	O
3	16	mice	NNS	O	I-NP	B-Animal
3	17	_	NN	O	I-NP	O
3	18	whose	WP$	O	B-NP	O
3	19	own	JJ	O	I-NP	O
3	20	bone	NN	O	I-NP	O
3	21	marrow	NN	O	I-NP	O
3	22	had	VBD	O	B-VP	O
3	23	been	VBN	O	I-VP	O
3	24	destroyed	VBN	O	I-VP	O
3	25	with	IN	O	B-PP	O
3	26	radiation	NN	O	B-NP	O
3	27	.	.	O	O	O

4	0	The	DT	O	B-NP	O
4	1	surprise	NN	O	I-NP	O
4	2	was	VBD	O	B-VP	O
4	3	that	IN	O	O	O
4	4	the	DT	O	B-NP	O
4	5	stem	VBP	O	B-VP	B-Jour
4	6	cells	NNS	O	B-NP	I-Jour
4	7	also	RB	O	O	O
4	8	generated	VBD	O	B-VP	O
4	9	healthy	JJ	O	B-NP	O
4	10	mature	JJ	O	I-NP	O
4	11	muscle	NN	O	I-NP	O
4	12	cells	NNS	O	I-NP	O
4	13	that	WDT	O	B-NP	O
4	14	found	VBN	O	B-VP	O
4	15	their	PP$	O	B-NP	O
4	16	way	NN	O	I-NP	O
4	17	through	IN	O	B-PP	O
4	18	the	DT	O	B-NP	O
4	19	blood	NN	O	I-NP	O
4	20	stream	NN	O	I-NP	O
4	21	to	TO	O	B-PP	O
4	22	the	DT	O	B-NP	O
4	23	wasted	VBN	O	I-NP	O
4	24	skeletal	JJ	O	I-NP	B-Medical
4	25	muscles	NNS	O	I-NP	O
4	26	of	IN	O	B-PP	O
4	27	the	DT	O	B-NP	O
4	28	mice	NNS	O	I-NP	B-Animal
4	29	COMMA	COMMA	O	O	O
4	30	and	CC	O	B-PP	O
4	31	to	TO	O	B-PP	O
4	32	a	DT	O	B-NP	O
4	33	small	JJ	O	I-NP	O
4	34	degree	NN	O	I-NP	O
4	35	COMMA	COMMA	O	O	O
4	36	restored	VBD	O	B-VP	O
4	37	them	PRP	O	B-NP	O
4	38	.	.	O	O	O

5	0	If	IN	O	O	O
5	1	these	DT	O	B-NP	O
5	2	immature	JJ	O	I-NP	O
5	3	bone	NN	O	I-NP	O
5	4	marrow	NN	O	I-NP	O
5	5	stem	VBP	O	B-VP	B-Jour
5	6	cells	NNS	O	B-NP	I-Jour
5	7	can	MD	O	B-VP	O
5	8	give	VB	O	I-VP	O
5	9	rise	VB	O	B-NP	O
5	10	to	TO	O	O	O
5	11	muscle	VB	O	O	O
5	12	cells	NNS	O	B-NP	O
5	13	COMMA	COMMA	O	O	O
5	14	they	PRP	O	B-NP	O
5	15	might	MD	O	B-VP	O
5	16	also	RB	O	I-VP	O
5	17	prove	VB	O	I-VP	O
5	18	to	TO	O	I-VP	O
5	19	be	VB	O	I-VP	O
5	20	a	DT	O	B-NP	O
5	21	source	NN	O	I-NP	O
5	22	of	IN	O	B-PP	O
5	23	repair	VBP	O	O	O
5	24	cells	NNS	O	B-NP	O
5	25	for	IN	O	B-PP	O
5	26	other	JJ	O	B-NP	O
5	27	kinds	NNS	O	I-NP	O
5	28	of	IN	O	B-PP	O
5	29	tissues	NNS	O	B-NP	O
5	30	in	IN	O	B-PP	B-Medical
5	31	the	DT	O	B-NP	I-Medical
5	32	body	NN	O	I-NP	I-Medical
5	33	COMMA	COMMA	O	O	O
5	34	say	VBP	O	B-VP	O
5	35	the	DT	O	B-NP	O
5	36	scientists	NNS	O	I-NP	B-ProfTitle
5	37	COMMA	COMMA	O	O	O
5	38	led	VBN	O	B-VP	O
5	39	by	IN	O	B-PP	O
5	40	Richard	NNP	O	B-NP	B-Peop
5	41	Mulligan	NNP	O	I-NP	I-Peop
5	42	and	CC	O	O	O
5	43	Louis	NNP	O	B-NP	B-Peop
5	44	Kunkel	NNP	O	I-NP	I-Peop
5	45	of	IN	O	B-PP	O
5	46	Children	NNP	O	B-NP	O
5	47	's	POS	O	B-NP	O
5	48	and	CC	O	O	O
5	49	Harvard	NNP	O	B-NP	B-OrgCorp
5	50	Medical	NNP	O	I-NP	I-OrgCorp
5	51	School	NNP	O	I-NP	I-OrgCorp
5	52	.	.	O	O	O

6	0	This	DT	O	B-NP	O
6	1	line	NN	O	I-NP	O
6	2	of	IN	O	B-PP	O
6	3	research	NN	O	B-NP	O
6	4	could	MD	O	B-VP	O
6	5	create	VB	O	I-VP	O
6	6	a	DT	O	B-NP	O
6	7	new	JJ	O	I-NP	O
6	8	kind	NN	O	I-NP	O
6	9	of	IN	O	O	O
6	10	stem	VBP	O	B-VP	O
6	11	cell	NN	O	B-NP	O
6	12	therapy	NN	O	I-NP	B-Medical
6	13	for	IN	O	B-PP	O
6	14	a	DT	O	B-NP	O
6	15	range	NN	O	I-NP	O
6	16	of	IN	O	B-PP	O
6	17	disorders	NNS	O	B-NP	O
6	18	COMMA	COMMA	O	O	O
6	19	they	PRP	O	B-NP	O
6	20	said	VBD	O	B-VP	O
6	21	.	.	O	O	O

7	0	Emanuela	NNP	O	B-NP	B-Peop
7	1	Gussoni	NNP	O	I-NP	I-Peop
7	2	COMMA	COMMA	O	O	O
7	3	a	DT	O	B-NP	O
7	4	biologist	NN	O	I-NP	B-ProfTitle
7	5	in	IN	O	B-PP	O
7	6	Kunkel	NNP	O	B-NP	B-Loc
7	7	's	POS	O	B-NP	O
7	8	lab	NN	O	I-NP	O
7	9	and	CC	O	O	O
7	10	lead	VBP	O	B-VP	O
7	11	author	NN	O	B-NP	B-ProfTitle
7	12	on	IN	O	B-PP	O
7	13	the	DT	O	B-NP	O
7	14	paper	NN	O	I-NP	O
7	15	in	IN	O	B-PP	O
7	16	the	DT	O	B-NP	O
7	17	current	JJ	O	I-NP	O
7	18	journal	NN	O	I-NP	B-Jour
7	19	Nature	NN	O	I-NP	O
7	20	COMMA	COMMA	O	O	O
7	21	said	VBD	O	B-VP	O
7	22	the	DT	O	B-NP	O
7	23	findings	NNS	O	I-NP	O
7	24	are	VBP	O	B-VP	O
7	25	important	JJ	O	O	O
7	26	because	IN	O	O	O
7	27	``	``	O	O	O
7	28	in	IN	O	O	O
7	29	adult	NN	O	B-NP	O
7	30	tissues	NNS	O	I-NP	O
7	31	we	PRP	O	B-NP	O
7	32	may	MD	O	B-VP	O
7	33	have	VB	O	I-VP	O
7	34	a	DT	O	B-NP	O
7	35	reservoir	NN	O	I-NP	O
7	36	of	IN	O	O	O
7	37	stem	VBP	O	B-VP	B-Jour
7	38	cells	NNS	O	B-NP	I-Jour
7	39	that	WDT	O	B-NP	O
7	40	has	VBZ	O	B-VP	O
7	41	more	RBR	O	O	O
7	42	potential	NN	O	B-NP	O
7	43	than	IN	O	O	O
7	44	we	PRP	O	B-NP	O
7	45	think	VBP	O	B-VP	O
7	46	''	''	O	O	O
7	47	to	TO	O	B-VP	O
7	48	differentiate	VB	O	I-VP	O
7	49	into	IN	O	B-PP	O
7	50	other	JJ	O	B-NP	O
7	51	types	NNS	O	I-NP	O
7	52	of	IN	O	B-PP	O
7	53	cells	NNS	O	B-NP	O
7	54	.	.	O	O	O

8	0	One	CD	O	B-NP	B-Num
8	1	implication	NN	O	I-NP	B-Medical
8	2	is	VBZ	O	B-VP	O
8	3	that	IN	O	O	O
8	4	instead	RB	O	B-PP	O
8	5	of	IN	O	I-PP	O
8	6	having	VBG	O	B-VP	O
8	7	to	TO	O	I-VP	O
8	8	obtain	VB	O	I-VP	O
8	9	stem	VBP	O	O	B-Jour
8	10	cells	NNS	O	B-NP	I-Jour
8	11	from	IN	O	B-PP	O
8	12	embryos	NNS	O	B-NP	O
8	13	COMMA	COMMA	O	O	O
8	14	with	IN	O	B-PP	O
8	15	all	PDT	O	B-NP	O
8	16	the	DT	O	I-NP	O
8	17	ethical	JJ	O	I-NP	O
8	18	questions	NNS	O	I-NP	O
8	19	that	DT	O	B-NP	O
8	20	entails	VBZ	O	B-VP	O
8	21	COMMA	COMMA	O	O	O
8	22	researchers	NNS	O	B-NP	B-ProfTitle
8	23	may	MD	O	B-VP	O
8	24	be	VB	O	I-VP	O
8	25	able	JJ	O	O	O
8	26	to	TO	O	B-VP	O
8	27	use	VB	O	I-VP	O
8	28	bone	NN	O	B-NP	O
8	29	marrow	NN	O	I-NP	O
8	30	cells	NNS	O	I-NP	O
8	31	as	IN	O	B-PP	O
8	32	versatile	JJ	O	B-NP	O
8	33	``	``	O	I-NP	O
8	34	pluripotent	JJ	O	I-NP	O
8	35	''	''	O	I-NP	O
8	36	cells	NNS	O	I-NP	O
8	37	in	IN	O	B-PP	O
8	38	developing	VBG	O	B-NP	O
8	39	repairs	NNS	O	I-NP	O
8	40	for	IN	O	B-PP	O
8	41	diseased	JJ	O	B-NP	O
8	42	tissues	NNS	O	I-NP	O
8	43	.	.	O	O	O

9	0	In	IN	O	B-PP	O
9	1	a	DT	O	B-NP	O
9	2	related	VBD	O	O	O
9	3	COMMA	COMMA	O	O	O
9	4	reverse	JJ	O	B-NP	O
9	5	experiment	NN	O	I-NP	O
9	6	COMMA	COMMA	O	O	O
9	7	Gussoni	NNP	O	B-NP	B-Peop
9	8	and	CC	O	O	O
9	9	her	PP$	O	B-NP	O
9	10	colleagues	NNS	O	I-NP	O
9	11	isolated	VBD	O	B-VP	O
9	12	muscle	NN	O	B-NP	O
9	13	stem	VBP	O	B-VP	B-Jour
9	14	cells	NNS	O	B-NP	I-Jour
9	15	from	IN	O	B-PP	O
9	16	mice	NNS	O	B-NP	B-Animal
9	17	and	CC	O	O	O
9	18	showed	VBD	O	B-VP	O
9	19	that	IN	O	O	O
9	20	they	PRP	O	B-NP	O
9	21	could	MD	O	B-VP	O
9	22	generate	VB	O	I-VP	O
9	23	adult	JJ	O	B-NP	O
9	24	muscle	NN	O	I-NP	O
9	25	cells	NNS	O	I-NP	O
9	26	COMMA	COMMA	O	O	O
9	27	as	IN	O	O	O
9	28	expected	VBN	O	B-VP	O
9	29	COMMA	COMMA	O	O	O
9	30	but	CC	O	O	O
9	31	could	MD	O	B-VP	O
9	32	also	RB	O	I-VP	O
9	33	give	VB	O	I-VP	O
9	34	rise	NN	O	B-NP	O
9	35	to	TO	O	B-PP	O
9	36	bone	NN	O	B-NP	O
9	37	marrow	NN	O	I-NP	O
9	38	cells	NNS	O	I-NP	O
9	39	.	.	O	O	O

10	0	What	WP	O	B-NP	O
10	1	prompted	VBD	O	B-VP	O
10	2	some	DT	O	B-NP	O
10	3	of	IN	O	B-PP	O
10	4	the	DT	O	B-NP	O
10	5	muscle	NN	O	I-NP	O
10	6	stem	VBP	O	B-VP	B-Jour
10	7	cells	NNS	O	B-NP	I-Jour
10	8	to	TO	O	B-VP	O
10	9	take	VB	O	I-VP	O
10	10	the	DT	O	B-NP	O
10	11	bone	NN	O	I-NP	O
10	12	marrow	NN	O	I-NP	O
10	13	pathway	NN	O	I-NP	O
10	14	isn	NN	O	I-NP	O
10	15	't	NN	O	I-NP	O
10	16	known	VBN	O	B-VP	O
10	17	_	NN	O	B-NP	O
10	18	just	RB	O	O	O
10	19	as	IN	O	O	O
10	20	scientists	NNS	O	B-NP	B-ProfTitle
10	21	can	MD	O	O	O
10	22	't	NN	O	B-NP	O
10	23	say	VB	O	B-VP	O
10	24	why	WRB	O	O	O
10	25	some	DT	O	B-NP	O
10	26	of	IN	O	B-PP	O
10	27	the	DT	O	B-NP	O
10	28	bone	NN	O	I-NP	O
10	29	marrow	NN	O	I-NP	O
10	30	cells	NNS	O	I-NP	O
10	31	in	IN	O	B-PP	O
10	32	the	DT	O	B-NP	O
10	33	first	JJ	O	I-NP	B-Num
10	34	experiment	NN	O	I-NP	O
10	35	``	``	O	B-VP	O
10	36	decided	VBD	O	I-VP	O
10	37	''	''	O	O	O
10	38	'	''	O	O	O
10	39	to	TO	O	B-VP	O
10	40	become	VB	O	I-VP	O
10	41	muscle	NN	O	B-NP	O
10	42	cells	NNS	O	I-NP	O
10	43	.	.	O	O	O

11	0	But	CC	O	O	O
11	1	they	PRP	O	B-NP	O
11	2	suspect	VBP	O	B-VP	O
11	3	that	IN	O	O	O
11	4	these	DT	O	B-NP	O
11	5	biological	JJ	O	I-NP	B-Medical
11	6	decisions	NNS	O	I-NP	O
11	7	are	VBP	O	B-VP	O
11	8	made	VBN	O	I-VP	O
11	9	in	IN	O	B-PP	O
11	10	response	NN	O	B-NP	O
11	11	to	TO	O	B-PP	O
11	12	some	DT	O	B-NP	O
11	13	signals	NNS	O	I-NP	O
11	14	from	IN	O	B-PP	O
11	15	the	DT	O	B-NP	O
11	16	body	NN	O	I-NP	O
11	17	COMMA	COMMA	O	O	O
11	18	perhaps	RB	O	O	O
11	19	calling	VBG	O	B-VP	O
11	20	out	IN	O	O	O
11	21	for	IN	O	B-PP	O
11	22	help	VBP	O	B-NP	O
11	23	in	IN	O	B-PP	O
11	24	repairing	VBG	O	B-VP	O
11	25	tissues	NNS	O	B-NP	O
11	26	.	.	O	O	O

12	0	Dr.	NNP	O	B-NP	B-ProfTitle
12	1	Leon	NNP	O	I-NP	B-Peop
12	2	Charash	NNP	O	I-NP	I-Peop
12	3	COMMA	COMMA	O	O	O
12	4	chairman	NN	O	B-NP	O
12	5	of	IN	O	B-PP	O
12	6	the	DT	O	B-NP	O
12	7	medical	JJ	O	I-NP	O
12	8	advisory	JJ	O	I-NP	O
12	9	committee	NN	O	I-NP	O
12	10	of	IN	O	B-PP	O
12	11	the	DT	O	B-NP	O
12	12	Muscular	NNP	O	I-NP	B-OrgCorp
12	13	Dystrophy	NNP	O	I-NP	I-OrgCorp
12	14	Association	NNP	O	I-NP	I-OrgCorp
12	15	COMMA	COMMA	O	O	O
12	16	called	VBD	O	B-VP	O
12	17	the	DT	O	B-NP	O
12	18	findings	NNS	O	I-NP	O
12	19	``	``	O	O	O
12	20	exciting	JJ	O	O	O
12	21	''	''	O	O	O
12	22	because	IN	O	O	O
12	23	``	``	O	O	O
12	24	the	DT	O	B-NP	O
12	25	work	NN	O	I-NP	O
12	26	may	MD	O	B-VP	O
12	27	eventually	RB	O	I-VP	O
12	28	lead	VB	O	I-VP	O
12	29	to	TO	O	B-PP	O
12	30	an	DT	O	B-NP	O
12	31	unanticipated	JJ	O	I-NP	O
12	32	treatment	NN	O	I-NP	O
12	33	approach	NN	O	I-NP	O
12	34	for	IN	O	B-PP	O
12	35	all	PDT	O	B-NP	O
12	36	the	DT	O	I-NP	O
12	37	muscles	NNS	O	I-NP	O
12	38	ravaged	VBN	O	B-VP	O
12	39	by	IN	O	B-PP	O
12	40	neuromuscular	JJ	O	B-NP	B-Medical
12	41	disease	NN	O	I-NP	B-Medical
12	42	.	.	O	O	O
12	43	''	''	O	O	O

13	0	Muscular	JJ	O	B-NP	O
13	1	dystrophies	NNS	O	I-NP	O
13	2	affect	VB	O	B-VP	O
13	3	some	DT	O	B-NP	O
13	4	250COMMA000	CD	O	I-NP	B-Num
13	5	Americans	NNPS	O	I-NP	B-LangRace
13	6	.	.	O	O	O

14	0	In	IN	O	B-PP	O
14	1	1986	CD	O	B-NP	B-Date
14	2	COMMA	COMMA	O	O	O
14	3	Kunkel	NNP	O	B-NP	B-Peop
14	4	identified	VBN	O	B-VP	O
14	5	the	DT	O	B-NP	O
14	6	gene	NN	O	I-NP	O
14	7	causing	VBG	O	B-VP	O
14	8	Duchenne	NNP	O	B-NP	O
14	9	muscular	JJ	O	I-NP	B-Medical
14	10	dystrophy	NN	O	I-NP	I-Medical
14	11	COMMA	COMMA	O	O	O
14	12	or	CC	O	O	O
14	13	DMD	NNP	O	B-NP	B-Org
14	14	COMMA	COMMA	O	O	O
14	15	which	WDT	O	B-NP	O
14	16	affects	VBZ	O	B-VP	O
14	17	mainly	RB	O	O	O
14	18	boys	NNS	O	B-NP	O
14	19	and	CC	O	O	O
14	20	is	VBZ	O	B-VP	O
14	21	ultimately	RB	O	O	O
14	22	fatal	JJ	O	O	B-Medical
14	23	.	.	O	O	O

15	0	Kunkel	NNP	O	B-NP	B-Peop
15	1	and	CC	O	O	O
15	2	his	PP$	O	B-NP	O
15	3	colleagues	NNS	O	I-NP	O
15	4	also	RB	O	O	O
15	5	identified	VBD	O	B-VP	O
15	6	the	DT	O	B-NP	O
15	7	protein	NN	O	I-NP	B-Medical
15	8	made	VBD	O	B-VP	O
15	9	by	IN	O	B-PP	O
15	10	the	DT	O	B-NP	O
15	11	normal	JJ	O	I-NP	O
15	12	DMD	NNP	O	I-NP	O
15	13	gene	NN	O	I-NP	O
15	14	COMMA	COMMA	O	O	O
15	15	and	CC	O	O	O
15	16	named	VBD	O	B-VP	O
15	17	it	PRP	O	B-NP	O
15	18	dystrophin	NN	O	B-NP	O
15	19	.	.	O	O	O

16	0	The	DT	O	B-NP	O
16	1	muscles	NNS	O	I-NP	O
16	2	of	IN	O	B-PP	O
16	3	DMD	NNP	O	B-NP	B-Org
16	4	patients	NNS	O	I-NP	O
16	5	waste	VBP	O	B-VP	O
16	6	because	IN	O	O	O
16	7	they	PRP	O	B-NP	O
16	8	lack	VBP	O	B-VP	O
16	9	dystrophin	NN	O	B-NP	O
16	10	.	.	O	O	O

17	0	The	DT	O	B-NP	O
17	1	gene	NN	O	I-NP	O
17	2	discovery	NN	O	I-NP	O
17	3	prompted	VBD	O	B-VP	O
17	4	a	DT	O	B-NP	O
17	5	series	NN	O	I-NP	O
17	6	of	IN	O	B-PP	O
17	7	efforts	NNS	O	B-NP	O
17	8	to	TO	O	B-VP	O
17	9	restore	VB	O	I-VP	O
17	10	DMD	NNP	O	B-NP	O
17	11	patients	NNS	O	I-NP	O
17	12	'	POS	O	B-NP	O
17	13	muscles	NNS	O	I-NP	O
17	14	COMMA	COMMA	O	O	O
17	15	without	IN	O	B-PP	O
17	16	success	NN	O	B-NP	O
17	17	to	TO	O	B-PP	O
17	18	date	VB	O	O	O
17	19	.	.	O	O	O

18	0	One	CD	O	B-NP	B-Num
18	1	tack	NN	O	I-NP	O
18	2	has	VBZ	O	B-VP	O
18	3	been	VBN	O	I-VP	O
18	4	to	TO	O	B-VP	O
18	5	take	VB	O	I-VP	O
18	6	donor	NN	O	B-NP	B-Medical
18	7	muscle	NN	O	I-NP	O
18	8	cells	NNS	O	I-NP	O
18	9	COMMA	COMMA	O	O	O
18	10	called	VBN	O	B-VP	O
18	11	myoblasts	NNS	O	B-NP	O
18	12	COMMA	COMMA	O	O	O
18	13	and	CC	O	O	O
18	14	transplant	VB	O	B-VP	O
18	15	them	PRP	O	B-NP	O
18	16	into	IN	O	B-PP	O
18	17	patients	NNS	O	B-NP	O
18	18	'	POS	O	B-NP	O
18	19	muscles	NNS	O	I-NP	O
18	20	.	.	O	O	O

19	0	This	DT	O	B-NP	O
19	1	takes	VBZ	O	B-VP	O
19	2	hundreds	NNS	O	B-NP	B-Num
19	3	or	CC	O	I-NP	O
19	4	thousands	NNS	O	I-NP	B-Num
19	5	of	IN	O	B-PP	O
19	6	separate	JJ	O	B-NP	O
19	7	injections	NNS	O	I-NP	O
19	8	COMMA	COMMA	O	O	O
19	9	and	CC	O	O	O
19	10	has	VBZ	O	B-VP	O
19	11	not	RB	O	I-VP	O
19	12	been	VBN	O	I-VP	O
19	13	proven	VBN	O	I-VP	O
19	14	to	TO	O	I-VP	O
19	15	increase	VB	O	I-VP	O
19	16	strength	NN	O	B-NP	O
19	17	.	.	O	O	O

20	0	Another	DT	O	B-NP	O
20	1	tack	NN	O	I-NP	O
20	2	uses	VBZ	O	B-VP	O
20	3	viruses	NNS	O	B-NP	O
20	4	to	TO	O	B-VP	O
20	5	carry	VB	O	I-VP	O
20	6	the	DT	O	B-NP	O
20	7	dystrophin	NN	O	I-NP	O
20	8	gene	NN	O	I-NP	O
20	9	into	IN	O	B-PP	O
20	10	patients	NNS	O	B-NP	O
20	11	'	POS	O	B-NP	O
20	12	muscles	NNS	O	I-NP	O
20	13	.	.	O	O	O

21	0	But	CC	O	O	O
21	1	this	DT	O	B-NP	O
21	2	approach	NN	O	I-NP	O
21	3	has	VBZ	O	B-VP	O
21	4	suffered	VBN	O	I-VP	O
21	5	from	IN	O	B-PP	O
21	6	a	DT	O	B-NP	O
21	7	larger	JJR	O	I-NP	O
21	8	problem	NN	O	I-NP	O
21	9	in	IN	O	B-PP	O
21	10	gene	NN	O	B-NP	O
21	11	therapy	NN	O	I-NP	B-Medical
21	12	COMMA	COMMA	O	O	O
21	13	that	IN	O	O	O
21	14	the	DT	O	B-NP	O
21	15	patient	NN	O	I-NP	B-Medical
21	16	's	POS	O	B-NP	O
21	17	immune	JJ	O	I-NP	B-Medical
21	18	system	NN	O	I-NP	O
21	19	attacks	VBZ	O	B-VP	O
21	20	the	DT	O	B-NP	O
21	21	foreign	JJ	O	I-NP	O
21	22	virus	NN	O	I-NP	O
21	23	and	CC	O	I-NP	O
21	24	genes	NNS	O	I-NP	O
21	25	and	CC	O	O	O
21	26	destroys	VBZ	O	B-VP	O
21	27	them	PRP	O	B-NP	O
21	28	.	.	O	O	O

22	0	Against	IN	O	B-PP	O
22	1	this	DT	O	B-NP	O
22	2	background	NN	O	I-NP	O
22	3	COMMA	COMMA	O	O	O
22	4	the	DT	O	B-NP	O
22	5	new	JJ	O	I-NP	O
22	6	experiments	NNS	O	I-NP	O
22	7	are	VBP	O	B-VP	O
22	8	encouraging	VBG	O	I-VP	O
22	9	because	IN	O	O	O
22	10	the	DT	O	B-NP	O
22	11	stem	VBP	O	B-VP	B-Jour
22	12	cells	NNS	O	B-NP	I-Jour
22	13	are	VBP	O	B-VP	O
22	14	the	DT	O	B-NP	O
22	15	patient	NN	O	I-NP	B-Medical
22	16	's	POS	O	B-NP	O
22	17	own	JJ	O	I-NP	O
22	18	COMMA	COMMA	O	O	O
22	19	and	CC	O	O	O
22	20	because	IN	O	O	O
22	21	the	DT	O	B-NP	O
22	22	cells	NNS	O	I-NP	O
22	23	are	VBP	O	B-VP	O
22	24	carried	VBN	O	I-VP	O
22	25	throughout	IN	O	B-PP	O
22	26	the	DT	O	B-NP	O
22	27	muscles	NNS	O	I-NP	O
22	28	via	IN	O	B-PP	O
22	29	blood	NN	O	B-NP	O
22	30	vessels	NNS	O	I-NP	O
22	31	.	.	O	O	O

23	0	The	DT	O	B-NP	O
23	1	existence	NN	O	I-NP	O
23	2	of	IN	O	B-PP	O
23	3	the	DT	O	B-NP	O
23	4	special	JJ	O	I-NP	O
23	5	stem	VBP	O	B-VP	B-Jour
23	6	cells	NNS	O	B-NP	I-Jour
23	7	that	WDT	O	B-NP	O
23	8	proved	VBD	O	B-VP	O
23	9	so	RB	O	O	O
23	10	versatile	JJ	O	O	O
23	11	in	IN	O	B-PP	O
23	12	the	DT	O	B-NP	O
23	13	experiment	NN	O	I-NP	O
23	14	had	VBD	O	B-VP	O
23	15	been	VBN	O	I-VP	O
23	16	known	VBN	O	I-VP	O
23	17	for	IN	O	B-PP	O
23	18	several	JJ	O	B-NP	O
23	19	years	NNS	O	I-NP	B-Date
23	20	.	.	O	O	O

24	0	They	PRP	O	B-NP	O
24	1	are	VBP	O	B-VP	O
24	2	even	RB	O	O	O
24	3	more	RBR	O	O	O
24	4	immature	JJ	O	O	O
24	5	COMMA	COMMA	O	O	O
24	6	or	CC	O	O	O
24	7	``	``	O	B-NP	O
24	8	primativeCOMMA	NN	O	I-NP	O
24	9	''	''	O	O	O
24	10	than	IN	O	B-PP	O
24	11	the	DT	O	B-NP	O
24	12	stem	VBP	O	B-VP	B-Jour
24	13	cells	NNS	O	B-NP	I-Jour
24	14	used	VBN	O	B-VP	O
24	15	in	IN	O	B-PP	O
24	16	current	JJ	O	B-NP	O
24	17	bone	NN	O	I-NP	O
24	18	marrow	NN	O	I-NP	O
24	19	therapy	NN	O	I-NP	B-Medical
24	20	.	.	O	O	O

25	0	Mulligan	NNP	O	B-NP	B-Peop
25	1	COMMA	COMMA	O	O	O
25	2	who	WP	O	B-NP	O
25	3	heads	VBZ	O	B-VP	O
25	4	the	DT	O	B-NP	O
25	5	gene	NN	O	I-NP	O
25	6	therapy	NN	O	I-NP	B-Medical
25	7	program	NN	O	I-NP	O
25	8	at	IN	O	B-PP	O
25	9	Harvard	NNP	O	B-NP	B-Org
25	10	and	CC	O	O	O
25	11	its	PP$	O	B-NP	O
25	12	affiliated	VBN	O	I-NP	O
25	13	hospitals	NNS	O	I-NP	O
25	14	COMMA	COMMA	O	O	O
25	15	refined	JJ	O	B-NP	O
25	16	a	DT	O	I-NP	O
25	17	laboratory	NN	O	I-NP	O
25	18	method	NN	O	I-NP	O
25	19	for	IN	O	B-PP	O
25	20	sorting	VBG	O	B-VP	O
25	21	out	IN	O	B-PP	O
25	22	the	DT	O	B-NP	O
25	23	special	JJ	O	I-NP	O
25	24	stem	NN	O	I-NP	B-Jour
25	25	cells	NNS	O	I-NP	I-Jour
25	26	COMMA	COMMA	O	O	O
25	27	a	DT	O	B-NP	O
25	28	rare	JJ	O	I-NP	O
25	29	population	NN	O	I-NP	O
25	30	called	VBD	O	B-VP	O
25	31	SP	NNP	O	B-NP	O
25	32	stem	VBP	O	B-VP	B-Jour
25	33	cells	NNS	O	B-NP	I-Jour
25	34	.	.	O	O	O

26	0	The	DT	O	B-NP	O
26	1	results	NNS	O	I-NP	O
26	2	COMMA	COMMA	O	O	O
26	3	he	PRP	O	B-NP	O
26	4	said	VBD	O	B-VP	O
26	5	in	IN	O	B-PP	O
26	6	a	DT	O	B-NP	O
26	7	recent	JJ	O	I-NP	O
26	8	interview	NN	O	I-NP	O
26	9	COMMA	COMMA	O	O	O
26	10	``	``	O	O	O
26	11	tell	VBP	O	B-VP	O
26	12	us	PRP	O	B-NP	O
26	13	that	IN	O	O	O
26	14	we	PRP	O	B-NP	O
26	15	may	MD	O	B-VP	O
26	16	want	VB	O	I-VP	O
26	17	to	TO	O	I-VP	O
26	18	look	VB	O	I-VP	O
26	19	in	IN	O	B-PP	O
26	20	far	RB	O	B-NP	O
26	21	greater	JJR	O	I-NP	O
26	22	detail	NN	O	I-NP	O
26	23	at	IN	O	B-PP	O
26	24	the	DT	O	B-NP	O
26	25	possiblity	NN	O	I-NP	O
26	26	of	IN	O	B-PP	O
26	27	bone	NN	O	B-NP	B-Jour
26	28	marrow	NN	O	I-NP	I-Jour
26	29	transplantation	NN	O	I-NP	I-Jour
26	30	used	VBD	O	B-VP	O
26	31	to	TO	O	B-VP	O
26	32	treat	VB	O	I-VP	O
26	33	a	DT	O	B-NP	O
26	34	range	NN	O	I-NP	O
26	35	of	IN	O	B-PP	O
26	36	diseases	NNS	O	B-NP	O
26	37	affecting	VBG	O	B-VP	O
26	38	the	DT	O	B-NP	O
26	39	heart	NN	O	I-NP	B-Medical
26	40	COMMA	COMMA	O	O	O
26	41	pancreas	NN	O	B-NP	O
26	42	COMMA	COMMA	O	I-NP	O
26	43	liver	NN	O	I-NP	O
26	44	and	CC	O	O	O
26	45	so	RB	O	O	O
26	46	forth	RB	O	O	O
26	47	.	.	O	O	O
26	48	''	''	O	O	O

27	0	Moreover	RB	O	O	O
27	1	COMMA	COMMA	O	O	O
27	2	he	PRP	O	B-NP	O
27	3	said	VBD	O	B-VP	O
27	4	COMMA	COMMA	O	O	O
27	5	``	``	O	O	O
27	6	it	PRP	O	B-NP	O
27	7	seems	VBZ	O	B-VP	O
27	8	that	IN	O	O	O
27	9	our	PP$	O	B-NP	O
27	10	blood	NN	O	I-NP	O
27	11	fulfills	VBZ	O	B-VP	O
27	12	a	DT	O	B-NP	O
27	13	far	RB	O	I-NP	O
27	14	greater	JJR	O	I-NP	O
27	15	wound-healing	JJ	O	I-NP	O
27	16	function	NN	O	I-NP	O
27	17	than	IN	O	O	O
27	18	we	PRP	O	B-NP	O
27	19	ever	RB	O	O	O
27	20	thought	VBD	O	B-VP	O
27	21	.	.	O	O	O
27	22	''	''	O	O	O
